Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole Continuous vs Episodic Therapy for OPC in HIV
NCT00000951Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of fluconazole in oropharyngeal candidiasis (OPC), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
fluconazole
03
Conditions
oropharyngeal candidiasis (OPC)
Beyond the preview
Go deeper on NCT00000951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000951.